Literature DB >> 14963108

Characterization of the interactions of estrogen receptor and MNAR in the activation of cSrc.

Frank Barletta1, Chi-Wai Wong, Chris McNally, Barry S Komm, Benita Katzenellenbogen, Boris J Cheskis.   

Abstract

In this study, we have evaluated the molecular mechanism of Src activation after its interaction with estrogen receptor alpha (ERalpha) and a newly identified scaffold protein, called MNAR (modulator of nongenomic activity of ER). Under basal condition, Src enzymatic activity is inhibited by intramolecular interactions. The enzyme can be activated by interaction between the SH2 domain of Src and phosphotyrosine-containing sequences and/or by interaction between the SH3 domain of Src and proteins containing PXXP motifs. Mutational analysis and functional evaluation of MNAR and the use of ERalpha and cSrc mutants revealed that MNAR interacts with Src's SH3 domain via its N-terminal PXXP motif. Mutation of this motif abolished both the MNAR-induced activation of Src and the stimulation of ER transcriptional activity. ER interacts with Src's SH2 domain using phosphotyrosine 537, and this complex was further stabilized by MNAR-ER interaction. Mapping studies reveal that both the A/B domain and Y537 of ERalpha are required for MNAR-induced activation of ER transcriptional activity. The region responsible for MNAR interaction with ER maps to two N-terminal LXXLL motifs of MNAR. Mutation of these motifs prevented ER-MNAR complex formation and eliminated activation of the Src/MAPK pathway. These data explicate how the coordinate interactions between MNAR, ER, and Src lead to Src activation. Our findings also demonstrate that MNAR is a scaffold protein that mediates ER-Src interaction and plays an important role in the integration of ER action in Src-mediated signaling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14963108     DOI: 10.1210/me.2003-0335

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  48 in total

Review 1.  Extranuclear signaling by estrogen: role in breast cancer progression and metastasis.

Authors:  V Cortez; M Mann; D W Brann; R K Vadlamudi
Journal:  Minerva Ginecol       Date:  2010-12

Review 2.  Rapid signaling mechanisms of estrogens in the developing cerebellum.

Authors:  Scott M Belcher
Journal:  Brain Res Rev       Date:  2007-09-14

3.  Variant estrogen receptor-c-Src molecular interdependence and c-Src structural requirements for endothelial NO synthase activation.

Authors:  Lei Li; Koji Hisamoto; Kyung Hee Kim; M Page Haynes; Philip M Bauer; Archana Sanjay; Mark Collinge; Roland Baron; William C Sessa; Jeffrey R Bender
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-05       Impact factor: 11.205

Review 4.  Non-nuclear estrogen receptor signaling in the endothelium.

Authors:  Qian Wu; Ken Chambliss; Michihisa Umetani; Chieko Mineo; Philip W Shaul
Journal:  J Biol Chem       Date:  2011-02-22       Impact factor: 5.157

5.  Increased PELP1 expression in rat periodontal ligament tissue in response to estrogens treatment.

Authors:  Jing Wang; Qiang Zhu; Shujun Song; Jun Dong; Lixin Shi; Ran Tao; Yin Ding; Baofa Hong
Journal:  J Mol Histol       Date:  2013-02-24       Impact factor: 2.611

6.  Liganded ERα Stimulates the E3 Ubiquitin Ligase Activity of UBE3C to Facilitate Cell Proliferation.

Authors:  Maiko Okada; Fumiaki Ohtake; Hiroyuki Nishikawa; Wenwen Wu; Yasushi Saeki; Keiji Takana; Tomohiko Ohta
Journal:  Mol Endocrinol       Date:  2015-09-21

7.  Delayed and persistent ERK1/2 activation is required for 4-hydroxytamoxifen-induced cell death.

Authors:  Jian-Hua Zhou; David V Yu; Jingwei Cheng; David J Shapiro
Journal:  Steroids       Date:  2007-07-07       Impact factor: 2.668

8.  Deregulation of estrogen receptor coactivator proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor in human endometrial tumors.

Authors:  Ratna K Vadlamudi; Seetharaman Balasenthil; Russell R Broaddus; Jan-Ake Gustafsson; Rakesh Kumar
Journal:  J Clin Endocrinol Metab       Date:  2004-12       Impact factor: 5.958

Review 9.  PELP1: A novel therapeutic target for hormonal cancers.

Authors:  Dimple Chakravarty; Rajeshwar Rao Tekmal; Ratna K Vadlamudi
Journal:  IUBMB Life       Date:  2010-03       Impact factor: 3.885

10.  Estrogen Regulation of MicroRNA Expression.

Authors:  Carolyn M Klinge
Journal:  Curr Genomics       Date:  2009-05       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.